StockData
CytoDyn Inc. logo

CytoDyn Inc. (CYDY) stock

CYDYOTCPharmaceutical PreparationsFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 14, 2026Score 4/30
$0.25+0.02 (+9.53%)

Close on Oct 19, 2026Market cap $345.56MP/E –Yield –

CytoDyn enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

CytoDyn's enterprise value was $347.23M on Oct 19, 2026, against $287.26M a year earlier. Over the last 5 years it ranged from $108.90M to $798.06M, with a median of $269.72M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$347.23M+1.4%
2025Dec 31, 2025$342.56M+214.6%
2024Dec 31, 2024$108.90M-40.9%
2023Dec 29, 2023$184.16M+1.1%
2022Dec 30, 2022$182.14M-71.1%
2021Dec 31, 2021$630.71M-79.3%
2020Dec 31, 2020$3.05B+700.1%
2019Dec 31, 2019$381.63M+263.1%
2018Dec 31, 2018$105.10M+26.5%
2017Dec 29, 2017$83.07M+6.2%
2016Dec 30, 2016$78.19M+69.3%
2015Dec 31, 2015$46.17M-25.3%
2014Dec 31, 2014$61.82M+76.7%
2013Dec 31, 2013$34.98M-13.8%
2012Dec 31, 2012$40.60M-38.6%
2011Dec 30, 2011$66.16M–

More CytoDyn figures

See a number that looks wrong?